Lotus 1-2-3 would quickly become the "killer app" for the nascent IBM-PC, doing for that system what VisiCalc had done earlier for Apple. 1-2-3's success (and corporate in-fighting between Personal Software and VisiCorp) drove VisiCalc sales into the ground almost immediately. Two years later, Lotus would buy out Personal Software. One year later, Lotus would kill VisiCalc. Today, Microsoft Excel documentation still references Lotus 1-2-3, not VisiCalc.
Click the Regenerate button to request a fresh analysis of the current plan.，更多细节参见新收录的资料
Organization Validated (OV),，这一点在新收录的资料中也有详细论述
潘柯强调，尽管希维她是药械联用产品，但其价值取决于给患者带来的临床获益，因此交易规模将与药品交易保持一致。这场围绕“一杯咖啡时间的无创治疗”的赌局，既是亚虹医药的生死突围，也是中国创新药从跟随到引领的缩影。（文丨公司观察，作者丨曹倩，编辑丨曹晟源），推荐阅读新收录的资料获取更多信息